89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 152 filers reported holding 89BIO INC in Q1 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,126,722 | +8.8% | 324,173 | -50.5% | 1.16% | +13.9% |
| Q3 2022 | $3,792,000 | +53.6% | 654,862 | -14.6% | 1.02% | +51.6% |
| Q2 2022 | $2,469,000 | +102.0% | 766,774 | +136.6% | 0.67% | +111.6% |
| Q1 2022 | $1,222,000 | -35.4% | 324,053 | +124.0% | 0.32% | -33.2% |
| Q4 2021 | $1,891,000 | -23.8% | 144,653 | +14.2% | 0.48% | -27.7% |
| Q3 2021 | $2,481,000 | +13.9% | 126,652 | +8.8% | 0.66% | +44.3% |
| Q2 2021 | $2,178,000 | -12.8% | 116,452 | +10.4% | 0.46% | -23.1% |
| Q1 2021 | $2,498,000 | -2.8% | 105,478 | 0.0% | 0.59% | -22.5% |
| Q4 2020 | $2,570,000 | -9.3% | 105,478 | -4.5% | 0.76% | -17.0% |
| Q3 2020 | $2,835,000 | +594.9% | 110,478 | +439.5% | 0.92% | +681.4% |
| Q2 2020 | $408,000 | – | 20,478 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orchard Capital Management, LLC | 551,879 | $7,025,420 | 2.36% |
| RA Capital Management | 8,955,410 | $114,002,369 | 2.31% |
| Cormorant Asset Management, LP | 2,550,000 | $32,462 | 2.17% |
| Deep Track Capital, LP | 3,850,000 | $49,010,500 | 2.06% |
| COMMODORE CAPITAL LP | 758,244 | $9,652 | 1.46% |
| Ikarian Capital, LLC | 454,000 | $5,779,419 | 1.39% |
| DAFNA Capital Management LLC | 324,173 | $4,126,722 | 1.16% |
| Parkman Healthcare Partners LLC | 332,880 | $4,237,562 | 1.13% |
| Boxer Capital, LLC | 1,400,000 | $17,822,000 | 0.94% |
| Orbimed Advisors | 3,658,869 | $46,577,402 | 0.89% |